$CTIC News Insider filings one way to track tr
Post# of 88915
Posted On: 01/04/2015 10:06:28 AM
$CTIC News
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com
Insider Trading Alert - CTIC, FXCM And CRM Traded By Insiders 10:45 a.m. Dec. 22, 2014 - TheStreet.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs 11:20 a.m. Dec. 16, 2014 - TheStreet.com
Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders 10:45 a.m. Dec. 8, 2014 - TheStreet.com
CTI BioPharma earns $15M milestone 7:46 a.m. Dec. 4, 2014 - Seeking Alpha
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders 11:00 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: CTI BIOPHARMA CORP 5:12 a.m. Oct. 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma's (CTIC) CEO James Bianco on Q3 2014 Results - Earnings Call Transcript 2:10 a.m. Oct. 30, 2014 - Seeking Alpha
CTI BioPharma (CTIC) Q3 2014 Results - Earnings Call Webcast 3:25 p.m. Oct. 29, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 7:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 7:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 7:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 12:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 7:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 9:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 9:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 9:56 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: CTI BIOPHARMA CORP 4:07 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells 1:30 a.m. Dec. 9, 2014 - PR Newswire - PRF
CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers 12:00 p.m. Dec. 6, 2014 - PR Newswire - PRF
CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX® 1:30 a.m. Dec. 4, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting 1:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
CTI BioPharma to Present at the Upcoming Investor Conferences 1:30 a.m. Nov. 17, 2014 - PR Newswire - PRF
CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock 9:15 a.m. Nov. 7, 2014 - PR Newswire - PRF
CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock 4:15 p.m. Nov. 6, 2014 - PR Newswire - PRF
CTI BioPharma Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 29, 2014 - PR Newswire - PRF
CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy 1:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 12:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 8:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 12:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 12:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 3:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 9:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 12:30 a.m. July 28, 2014 - PR Newswire - PRF
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 12:30 a.m. July 21, 2014 - PR Newswire - PRF
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 5:00 a.m. July 4, 2014 - PR Newswire - PRF
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com
Insider Trading Alert - CTIC, FXCM And CRM Traded By Insiders 10:45 a.m. Dec. 22, 2014 - TheStreet.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs 11:20 a.m. Dec. 16, 2014 - TheStreet.com
Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders 10:45 a.m. Dec. 8, 2014 - TheStreet.com
CTI BioPharma earns $15M milestone 7:46 a.m. Dec. 4, 2014 - Seeking Alpha
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders 11:00 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: CTI BIOPHARMA CORP 5:12 a.m. Oct. 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma's (CTIC) CEO James Bianco on Q3 2014 Results - Earnings Call Transcript 2:10 a.m. Oct. 30, 2014 - Seeking Alpha
CTI BioPharma (CTIC) Q3 2014 Results - Earnings Call Webcast 3:25 p.m. Oct. 29, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 7:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 7:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 7:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 12:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 7:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 9:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 9:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 9:56 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: CTI BIOPHARMA CORP 4:07 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells 1:30 a.m. Dec. 9, 2014 - PR Newswire - PRF
CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers 12:00 p.m. Dec. 6, 2014 - PR Newswire - PRF
CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX® 1:30 a.m. Dec. 4, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting 1:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
CTI BioPharma to Present at the Upcoming Investor Conferences 1:30 a.m. Nov. 17, 2014 - PR Newswire - PRF
CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock 9:15 a.m. Nov. 7, 2014 - PR Newswire - PRF
CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock 4:15 p.m. Nov. 6, 2014 - PR Newswire - PRF
CTI BioPharma Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 29, 2014 - PR Newswire - PRF
CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy 1:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 12:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 8:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 12:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 12:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 3:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 9:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 12:30 a.m. July 28, 2014 - PR Newswire - PRF
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 12:30 a.m. July 21, 2014 - PR Newswire - PRF
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 5:00 a.m. July 4, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼